Singapore, Aug 17, 2010: Embryonic stem cell (hESC) research has attracted a lot of attention world over, and the controversy surrounding it, just does not seem to die down. MarketResearch.com has announced the addition of Industry Experts' new report "Human Embryonic Stem Cells (hESC) - A Global Market Overview", to their collection of biotechnology market reports.

Stem cells are unspecialized cells that are capable of differentiating into any other cell type. In addition to being crucial for humans, stem cells also form an important tool in research, for finding cures for a host of diseases. Adult, umbilical cord blood and embryos constitute the three sources of stem cells, of which embryonic stem cells have been the subject of major research activities.

Embryonic Stem Cell Technologies analyzed in the study include stem cell transplants, cell based genomics, xenotransplants and other. The report also analyzes the market for hESC therapeutic areas including central nervous system (CNS), tissue engineering, oncology, cardiology and other disease areas. The worldwide market for hESCs is estimated at US$3.8 billion in 2010. Growing at a robust CAGR of 24.8 percent during the period 2007-2015, the market is projected to reach US$10.7 billion by 2015.

The report reviews, analyses and projects the hESCs market for global and the regional markets including North America, Europe, Asia-Pacific, and Rest of World. The regional markets further analyzed for 12 independent countries across North America -- United States, Canada and Mexico; Europe -- United Kingdom, Germany, France, Spain, Sweden and Rest of Europe; Asia-Pacific -- India, China, Japan, Australia and Rest of Asia-Pacific.